Selected research
Industry Research
Isoniazid Industry Research Report 2026
Market perspective
The global Isoniazid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Isoniazid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Isoniazid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Isoniazid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Isoniazid include AMSAL CHEM, Zhejiang Second Pharma, Taizhou Tianrui Pharmaceutical, Titan Pharma (India), Resonance Specialties, Camus pharma and Calyx Pharma & Chem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Isoniazid market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Isoniazid Market by Company
AMSAL CHEM
Zhejiang Second Pharma
Taizhou Tianrui Pharmaceutical
Titan Pharma (India)
Resonance Specialties
Camus pharma
Calyx Pharma & Chem
Isoniazid Segment by Type
Above 98% Isoniazid
Below 98% Isoniazid
Isoniazid Segment by Application
Hospital
Clinic
Others
Isoniazid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoniazid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isoniazid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoniazid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Isoniazid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Isoniazid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Isoniazid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98% Isoniazid
- Below 98% Isoniazid
Applications
- Hospital
- Clinic
- Others
Companies covered
- AMSAL CHEM
- Zhejiang Second Pharma
- Taizhou Tianrui Pharmaceutical
- Titan Pharma (India)
- Resonance Specialties
- Camus pharma
- Calyx Pharma & Chem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Isoniazid Market Size (2021-2032)
- 2.2.2 Global Isoniazid Sales (2021-2032)
- 2.2.3 Global Isoniazid Market Average Price (2021-2032)
- 2.3 Isoniazid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Above 98% Isoniazid
- 2.3.3 Below 98% Isoniazid
- 2.4 Isoniazid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Isoniazid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Isoniazid Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Isoniazid Revenue of Manufacturers (2021-2026)
- 3.4 Global Isoniazid Average Price by Manufacturers (2021-2026)
- 3.5 Global Isoniazid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Isoniazid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Isoniazid, Product Type & Application
- 3.8 Global Manufacturers of Isoniazid, Established Date
- 3.9 Global Isoniazid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AMSAL CHEM
- 4.1.1 AMSAL CHEM Company Information
- 4.1.2 AMSAL CHEM Business Overview
- 4.1.3 AMSAL CHEM Isoniazid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AMSAL CHEM Isoniazid Product Portfolio
- 4.1.5 AMSAL CHEM Recent Developments
- 4.2 Zhejiang Second Pharma
- 4.2.1 Zhejiang Second Pharma Company Information
- 4.2.2 Zhejiang Second Pharma Business Overview
- 4.2.3 Zhejiang Second Pharma Isoniazid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhejiang Second Pharma Isoniazid Product Portfolio
- 4.2.5 Zhejiang Second Pharma Recent Developments
- 4.3 Taizhou Tianrui Pharmaceutical
- 4.3.1 Taizhou Tianrui Pharmaceutical Company Information
- 4.3.2 Taizhou Tianrui Pharmaceutical Business Overview
- 4.3.3 Taizhou Tianrui Pharmaceutical Isoniazid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Taizhou Tianrui Pharmaceutical Isoniazid Product Portfolio
- 4.3.5 Taizhou Tianrui Pharmaceutical Recent Developments
- 4.4 Titan Pharma (India)
- 4.4.1 Titan Pharma (India) Company Information
- 4.4.2 Titan Pharma (India) Business Overview
- 4.4.3 Titan Pharma (India) Isoniazid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Titan Pharma (India) Isoniazid Product Portfolio
- 4.4.5 Titan Pharma (India) Recent Developments
- 4.5 Resonance Specialties
- 4.5.1 Resonance Specialties Company Information
- 4.5.2 Resonance Specialties Business Overview
- 4.5.3 Resonance Specialties Isoniazid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Resonance Specialties Isoniazid Product Portfolio
- 4.5.5 Resonance Specialties Recent Developments
- 4.6 Camus pharma
- 4.6.1 Camus pharma Company Information
- 4.6.2 Camus pharma Business Overview
- 4.6.3 Camus pharma Isoniazid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Camus pharma Isoniazid Product Portfolio
- 4.6.5 Camus pharma Recent Developments
- 4.7 Calyx Pharma & Chem
- 4.7.1 Calyx Pharma & Chem Company Information
- 4.7.2 Calyx Pharma & Chem Business Overview
- 4.7.3 Calyx Pharma & Chem Isoniazid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Calyx Pharma & Chem Isoniazid Product Portfolio
- 4.7.5 Calyx Pharma & Chem Recent Developments
5 Global Isoniazid Market Scenario by Region
- 5.1 Global Isoniazid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Isoniazid Sales by Region: 2021-2032
- 5.2.1 Global Isoniazid Sales by Region: 2021-2026
- 5.2.2 Global Isoniazid Sales by Region: 2027-2032
- 5.3 Global Isoniazid Revenue by Region: 2021-2032
- 5.3.1 Global Isoniazid Revenue by Region: 2021-2026
- 5.3.2 Global Isoniazid Revenue by Region: 2027-2032
- 5.4 North America Isoniazid Market Facts & Figures by Country
- 5.4.1 North America Isoniazid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Isoniazid Sales by Country (2021-2032)
- 5.4.3 North America Isoniazid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Isoniazid Market Facts & Figures by Country
- 5.5.1 Europe Isoniazid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Isoniazid Sales by Country (2021-2032)
- 5.5.3 Europe Isoniazid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Isoniazid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Isoniazid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Isoniazid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Isoniazid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Isoniazid Market Facts & Figures by Country
- 5.7.1 South America Isoniazid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Isoniazid Sales by Country (2021-2032)
- 5.7.3 South America Isoniazid Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Isoniazid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Isoniazid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Isoniazid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Isoniazid Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Isoniazid Sales by Type (2021-2032)
- 6.1.1 Global Isoniazid Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Isoniazid Sales Market Share by Type (2021-2032)
- 6.2 Global Isoniazid Revenue by Type (2021-2032)
- 6.2.1 Global Isoniazid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Isoniazid Revenue Market Share by Type (2021-2032)
- 6.3 Global Isoniazid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Isoniazid Sales by Application (2021-2032)
- 7.1.1 Global Isoniazid Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Isoniazid Sales Market Share by Application (2021-2032)
- 7.2 Global Isoniazid Revenue by Application (2021-2032)
- 7.2.1 Global Isoniazid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Isoniazid Revenue Market Share by Application (2021-2032)
- 7.3 Global Isoniazid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Isoniazid Value Chain Analysis
- 8.1.1 Isoniazid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Isoniazid Production Mode & Process
- 8.2 Isoniazid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Isoniazid Distributors
- 8.2.3 Isoniazid Customers
9 Global Isoniazid Analyzing Market Dynamics
- 9.1 Isoniazid Industry Trends
- 9.2 Isoniazid Industry Drivers
- 9.3 Isoniazid Industry Opportunities and Challenges
- 9.4 Isoniazid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst